CHOSA Stock Overview
Chosa Oncology AB develops oncology drugs for the treatment of cancer.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Chosa Oncology AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.53 |
| 52 Week High | kr2.25 |
| 52 Week Low | kr0.30 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 39.84% |
| 1 Year Change | -59.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| CHOSA | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 0% | 3.6% | 1.1% |
| 1Y | -59.3% | -3.2% | 8.6% |
Return vs Industry: CHOSA underperformed the Swedish Biotechs industry which returned -3.2% over the past year.
Return vs Market: CHOSA underperformed the Swedish Market which returned 8.6% over the past year.
Price Volatility
| CHOSA volatility | |
|---|---|
| CHOSA Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 10.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in SE Market | 13.5% |
| 10% least volatile stocks in SE Market | 3.6% |
Stable Share Price: CHOSA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CHOSA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | n/a | Peter Jensen | www.chosaoncology.com |
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB incorporated in 2022 and is based in Lund, Sweden.
Chosa Oncology AB Fundamentals Summary
| CHOSA fundamental statistics | |
|---|---|
| Market cap | kr34.38m |
| Earnings (TTM) | -kr23.94m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.4x
P/E RatioIs CHOSA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHOSA income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | kr0 |
| Gross Profit | kr0 |
| Other Expenses | kr23.94m |
| Earnings | -kr23.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | -0.37 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CHOSA perform over the long term?
See historical performance and comparison